Temple Therapeutics

#Womenhealth feels like a Ferris wheel—endlessly going in circles, with moments of hope at the top quickly followed by the frustration of being back where you started, stuck in a cycle of #misdiagnosis, #dismissal, and #delayed #care. Temple Therapeutics is laser-focused on Redefining What is Possible. Disagree with our script? Feedback welcomed. 👇 What are the problems we are solving? Temple Therapeutics is solving two of the biggest problems in women's health, focusing on four pillars within the ob/gyn field (#Gynecancers, #endometriosis, #fibroticdisorders and Polycystic Ovarian Syndrome-#PCOS). ☝ There are very few or no disease-modifying therapeutics. Marketed therapies are more akin to covering a structurally defective wall with a fresh coat of paint. ✌ For many women, getting a proper diagnosis for a medical condition feels like taking a shot in the dark—blindly hoping to hit the mark while doctors dismiss or downplay their symptoms. After years of being gaslighted, they're left second-guessing themselves, chasing one possible explanation after another, only to end up running on a hamster wheel—exhausted, stuck, and no closer to real answers. This cycle of misdiagnosis and frustration delays treatment, leaving countless women to suffer unnecessarily when what they really need is clarity, validation, and solutions that actually address their health concerns. 🗝️ 🔓 What is the Solution? #Targeted #therapeutics supported by #companiondiagnostics or disease #biomarkers based on #female #biology. 🥚 What is the source of our distinct value? Golden Goose--Proprietary access to validated biobanks from thousands of female patients gives us insights into female biology and understanding of diseases. Screen and validate disease-specific targets and biomarkers. A powerful engine that stands to leapfrog disease-modifying therapies and diagnostics. #innovation #womenshealth #gynecology #reproductive #medicine Photo by Erik Odiin on Unsplash

Thank you, Sharon Kedar, CFA Lucy Perez podcast on "Closing the $1 trillion (per annum) Women's Health Gap" (McKinsey & Company). It speaks to Temple Therapeutics two strategic axioms: 1. If the data does not represent you, it may not suit you. 2. If you cannot diagnose a disease, how can you treat it, develop products, or design trials? Temple Therapeutics, our three pillars—gynecological cancers, endometriosis, and fibrotic disorders—are supported by validated biobanks. This robust foundation allows us to lead a new era in precision medicine for women's health. We are dedicated to discovering new #biomarkers, #diagnostics, and disease-modifying treatments, truly redefining what is possible. #GynecologicalCancers #Endometriosis #FibroticDisorders #Biobanks #PrecisionMedicine #WomensHealth https://lnkd.in/gBsPbNbt